J 2022

Genetics of T2DM and Its Chronic Complications: Are We Any Closer to the Individual Prediction of Genetic Risk?

GALUŠKA, David; Lucie DLOUHÁ; Jaroslav HUBÁČEK and Kateřina KAŇKOVÁ

Basic information

Original name

Genetics of T2DM and Its Chronic Complications: Are We Any Closer to the Individual Prediction of Genetic Risk?

Authors

GALUŠKA, David (203 Czech Republic, belonging to the institution); Lucie DLOUHÁ (203 Czech Republic, guarantor); Jaroslav HUBÁČEK (203 Czech Republic) and Kateřina KAŇKOVÁ (203 Czech Republic, belonging to the institution)

Edition

FOLIA BIOLOGICA, PRAGUE, CHARLES UNIV PRAGUE, FIRST FACULTY MEDICINE, 2022, 0015-5500

Other information

Language

English

Type of outcome

Article in a journal

Field of Study

30101 Human genetics

Country of publisher

Czech Republic

Confidentiality degree

is not subject to a state or trade secret

References:

Impact factor

Impact factor: 0.600

RIV identification code

RIV/00216224:14110/22:00134644

Organization unit

Faculty of Medicine

UT WoS

001010557100001

EID Scopus

2-s2.0-85160966420

Keywords in English

diabetes mellitus; diabetes complication; polymorphism; Central European population; genetic; GWAS; diabetic neuropathy; diabetic kidney disease; diabetic retinopathy; cardiovascular disease

Tags

Tags

International impact, Reviewed
Changed: 9/8/2023 12:06, Mgr. Tereza Miškechová

Abstract

In the original language

Type 2 diabetes mellitus (T2DM) is a com-plex disease that has risen in global prevalence over recent decades, resulting in concomitant and enor-mous socio-economic impacts. In addition to the well-documented risk factors of obesity, poor dietary habits and sedentary lifestyles, genetic background plays a key role in the aetiopathogenesis of diabetes and the development of associated micro-and macro -vascular complications. Recent advances in genomic research, notably next-generation sequencing and ge-nome-wide association studies, have greatly improved the efficiency with which genetic backgrounds to com-plex diseases are analysed. To date, several hundred single-nucleotide polymorphisms have been associ-ated with T2DM or its complications. Given the poly -genic background to T2DM (and numerous other complex diseases), the degree of genetic predisposi-tion can be treated as a "continuous trait" quantified by a genetic risk score. Focusing mainly on the Central European population, this review summa-rizes recent state-of-the-art methods that have en-abled us to better determine the genetic architecture of T2DM and the utility of genetic risk scores in dis-ease prediction.

Links

NV18-01-00046, research and development project
Name: Genetické skóre v predikci rizika diabetu a jeho komplikací
Investor: Ministry of Health of the CR